Edematous response caused by [Thi5,8,D-Phe7]bradykinin, a B2 receptor antagonist, is due to mast cell degranulation.

MLA

Wang, J. P., et al. “Edematous Response Caused by [Thi5,8,D-Phe7]Bradykinin, a B2 Receptor Antagonist, Is Due to Mast Cell Degranulation.” European Journal of Pharmacology, vol. 161, no. 2–3, Feb. 1989, pp. 143–49. EBSCOhost, https://doi.org/10.1016/0014-2999(89)90836-4.

APA

Wang, J. P., Hsu, M. F., Ouyang, C. H., & Teng, C. M. (1989). Edematous response caused by [Thi5,8,D-Phe7]bradykinin, a B2 receptor antagonist, is due to mast cell degranulation. European Journal of Pharmacology, 161(2–3), 143–149. https://doi.org/10.1016/0014-2999(89)90836-4

Chicago

Wang, J P, M F Hsu, C H Ouyang, and C M Teng. 1989. “Edematous Response Caused by [Thi5,8,D-Phe7]Bradykinin, a B2 Receptor Antagonist, Is Due to Mast Cell Degranulation.” European Journal of Pharmacology 161 (2–3): 143–49. doi:10.1016/0014-2999(89)90836-4.